FPS has been advising medium-sized and larger pharmaceutical and medical device manufacturers on advertising issues for a number of years, assessing advertisements, websites, brochures, giveaways and other promotional material, for example, and addressing the associated issues of the admissibility or misleading nature of information featured in scientific statements, among other things, in the light of the Health Services and Products Advertising Act (HWG) and the Act Against Unfair Competition (UWG). In this field, FPS represents manufacturers in out-of-court processes involving competitors and competition associations and especially in disputes before the civil courts.

Digitalisation unlocks new opportunities for companies and creates space for future-oriented and scalable business models. Data has become the most valuable currency in the digital world. Data protection law – or now data law – is a separate advisory field at FPS rather than a mere annex to other areas of law. FPS helps companies to devise future-proof and legally compliant data usage concepts so that they can achieve their goals when using new technologies: innovation and data protection – when understood correctly – needn’t contradict one another. The GDPR with its drastic fines has significantly increased the risks for companies. FPS establishes what a company is permitted to do with the data and ensures compliance with data protection requirements in a pragmatic way by setting up a data protection management system, which, among other things, includes records of processing activities, data protection policies, data protection information, deletion and authorisation concepts, data protection impact assessments, processes for dealing with information and deletion requests from data subjects and much more besides. And if penalty proceedings are initiated, we defend our clients’ rights against the supervisory authorities. We also provide external data protection officers for our clients – for data protection from one single source.